- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02399579
Evaluation of a New Self-Assessed, Home-Based Symptom Score Test in Cat Allergic Patients
July 1, 2015 updated by: University of Zurich
The purpose of this study is to better standardize the symptom recording of cat allergic persons under real-life conditions.
A new self-assessed, home-based symptom score will be tested.
Study Overview
Detailed Description
In order to bring research on cat dander allergy a step further we aim to investigate cat dander allergy symptoms and record them in a natural environment, respectively, i.e. at the participant's home.
For this purpose we aim to test a new self-assessed, homebased symptom score (called HypoScore).
The participants will perform 8 provocation tests.
Every provocation test consists of petting the cat until the participants become symptomatic.
The participants have to pet the cat everytime in the same manner.
Directly before and after the provocation test the symptoms will be recorded in the eCRF by using an iPad mini.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zurich, Switzerland, 8091
- Clinical Trial Center of the University Hospital Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participant understands the nature, meaning and scope of the study.
- Signed Informed Consent after being informed.
- Male and Female patients 18 years to 65 years of age.
- Positive screening prick test (mean wheal diameter ≥ 3 mm) when tested with already standardized cat allergen extract.
- Positive screening prick test (wheal diameter ≥ 3mm) to Histamine dihydrochloride 10mg/ml.
- Positive Scratch Test when tested with cat dander sample of participant's cat.
- Baseline symptoms with a severity of at least "1" in minimal 2 various symptoms.
- Owner of a cat that lives in the same household.
Exclusion Criteria:
- Impaired in understanding the nature, meaning and scope of the study or incapable of giving written informed consent
- Participation in another study with investigational drug within the 30 days preceding and during the present study
- Women who are pregnant or breast feeding
- Intention to become pregnant during the course of the study
- Positive skin reaction in the prick test to negative control
- History of anaphylactic reaction to pet allergens
- Severe diseases influencing the results of the present study by discretion of the investigator
- Immunotherapy with fel d 1 / cat allergen preparation during the past two years
- Skin lesions and excessive hair-growth in the skin test areas
- Treatment with prohibited concomitant medications with the exception of medications with local effects which will not influence the results of the skin tests and the results of the other tests (testing period).
- The patient should not suffer from other respiratory allergies during this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: HypoScore
Provocation test.
Recording symptoms of cat allergic participants with the cat owner's cat: Before and after petting the cat.
|
The participants will perform 8 provocation tests.
Every provocation test consists of petting the cat until the participants become symptomatic.
The symptoms of cat allergic participants with the cat owner's cat will be recorded before and after petting the cat.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time until the participant becomes symptomatic
Time Frame: approx. 15 minutes (during Provocation Test)
|
How long can the owner pet his/her cat until he becomes symptomatic?
|
approx. 15 minutes (during Provocation Test)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of score points resulting from symptom score recording before and after the provocation test.
Time Frame: approx. 15 minutes (before and after provocation)
|
approx. 15 minutes (before and after provocation)
|
|
Visual Analogue Scale Values
Time Frame: approx. 5 minutes (before provocation)
|
approx. 5 minutes (before provocation)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Thomas M. Kündig, PD Dr. med., University of Zurich
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2015
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
June 1, 2015
Study Registration Dates
First Submitted
March 17, 2015
First Submitted That Met QC Criteria
March 25, 2015
First Posted (Estimate)
March 26, 2015
Study Record Updates
Last Update Posted (Estimate)
July 2, 2015
Last Update Submitted That Met QC Criteria
July 1, 2015
Last Verified
July 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZU-HypoScore-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cat Allergy
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedCat Allergy | Cat HypersensitivityUnited States
-
National Institute of Allergy and Infectious Diseases...Circassia LimitedCompletedCat Allergy | Cat HypersensitivityCanada
-
Johns Hopkins UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Genentech, Inc.CompletedCat AllergyUnited States
-
Circassia LimitedCetero Research, San Antonio; Adiga Life Sciences, Inc.Completed
-
Circassia LimitedAdiga Life Sciences, Inc.Completed
-
ALK-Abelló A/SCetero Research, San AntonioCompleted
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN); Tunitas Therapeutics, Inc.Terminated
-
Circassia LimitedAdiga Life Sciences, Inc.Completed
-
Circassia LimitedCompleted
Clinical Trials on Provocation test
-
Spital Limmattal SchlierenCompletedAnkle Fracture - Lateral Malleolus | Ankle Fracture, Trimalleolar | Ankle Fracture, BimalleolarSwitzerland
-
Lithuanian University of Health SciencesRecruiting
-
Centre Hospitalier Universitaire Saint PierreUniversité Libre de Bruxelles; Hopitaux Iris SudCompletedHyperventilation SyndromeBelgium
-
Mahidol UniversityCompletedOther Allergic RhinitisThailand
-
Baylor College of MedicineUniversity of Pittsburgh; Brown UniversityActive, not recruitingObsessive-Compulsive Disorder | OCDUnited States
-
Reuth Rehabilitation HospitalRecruitingMild Traumatic Brain Injury, Concussion | Post Traumatic Headache | Post Concussive Syndrome, ChronicIsrael
-
University Hospital, Strasbourg, FranceRecruiting
-
University Hospital, MontpellierCompleted
-
Centre Hospitalier Régional Metz-ThionvilleUniversity Hospital, Strasbourg, France; CHU de Reims; Centre Hospitalier de...TerminatedRespiratory Disease | Mite AllergyFrance
-
Central Hospital, Nancy, FranceCompletedChildhood Asthma